Electrophysiological effects of desflurane in children with Wolff-Parkinson-White syndrome: A randomized crossover study
Acta Anaesthesiologica Scandinavica Oct 30, 2017
Hino H, et al. - Researchers tested the validity of a presumption that, compared with propofol, desflurane prolongs the antegrade accessory pathway effective refractory period (APERP) in children undergoing radiofrequency catheter ablation for Wolff-Parkinson-White (WPW) syndrome. It was concluded that desflurane is not suitable for this patient population as it enhances the refractoriness and may block the electrical conduction of the atrioventricular accessory pathway.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries